Cameron Turtle, See Remarks at BridgeBio Pharma, Inc. (BBIO), sold 10,000 shares at $32.65 ($327K) on 2020-06-30, disclosed to the SEC on 2020-07-02.
Open-market sale of $327k BBIO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.65 | 9,700 | $317K | 97.0% |
| 2 | $33.17 | 300 | $10K | 3.0% |
| Total | $32.67 avg | 10,000 | $327K | 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $1.4M | — | Filing → |
| SYRE | SELL | 2026-07-02 | $1.3M | — | Filing → |
| SYRE | SELL | 2026-06-03 | $1.1M | — | Filing → |